Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1991 Dec 1;88(23):10377–10381. doi: 10.1073/pnas.88.23.10377

Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicing.

J Sperling 1, J Chebath 1, H Arad-Dann 1, D Offen 1, P Spann 1, R Lehrer 1, D Goldblatt 1, B Jolles 1, R Sperling 1
PMCID: PMC52931  PMID: 1720538

Abstract

The first step in splicing of pre-mRNA involves an intermediate lariat structure, in which a 2'5' phosphodiester bond between the 5' terminal guanosine residue of the intron and a specific adenosine residue near the 3' end of the intron is formed. A mammalian enzyme that generates 2'-5' phosphodiester bonds is (2'-5')oligoadenylate synthetase [(2'-5')OASE]. Although the expression of this enzyme is induced by interferon, low constitutive levels can be detected in untreated cells and tissues. The structural similarity between the lariat branch point and the 2'-5' phosphodiester bond generated by (2'-5')OASE prompted the experiments described here which suggest that this enzyme is involved in pre-mRNA splicing. (i) We show that a (2'-5')OASE activity is associated with 60S spliceosomes in an ATP- and RNA-dependent manner and that it can be indirectly immunoprecipitated by anti-Sm antibodies. (ii) Antibodies against (2'-5')OASE inhibit the lariat formation in the first step of splicing when added directly to a splicing reaction in vitro. (iii) HeLa cell nuclear extracts immunodepleted of (2'-5')OASE activity were also deficient in splicing activity.

Full text

PDF
10377

Images in this article

10378Image
on p.10378
10379Image
on p.10379
10380Image
on p.10380
10380Image
on p.10380
10380Image
on p.10380

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arad-Dann H., Isenberg D. A., Shoenfeld Y., Offen D., Sperling J., Sperling R. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis. J Immunol. 1987 Apr 15;138(8):2463–2468. [PubMed] [Google Scholar]
  2. Ast G., Goldblatt D., Offen D., Sperling J., Sperling R. A novel splicing factor is an integral component of 200S large nuclear ribonucleoprotein (InRNP) particles. EMBO J. 1991 Feb;10(2):425–432. doi: 10.1002/j.1460-2075.1991.tb07964.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Busch H., Reddy R., Rothblum L., Choi Y. C. SnRNAs, SnRNPs, and RNA processing. Annu Rev Biochem. 1982;51:617–654. doi: 10.1146/annurev.bi.51.070182.003153. [DOI] [PubMed] [Google Scholar]
  4. Cech T. R. The chemistry of self-splicing RNA and RNA enzymes. Science. 1987 Jun 19;236(4808):1532–1539. doi: 10.1126/science.2438771. [DOI] [PubMed] [Google Scholar]
  5. Chebath J., Benech P., Hovanessian A., Galabru J., Revel M. Four different forms of interferon-induced 2',5'-oligo(A) synthetase identified by immunoblotting in human cells. J Biol Chem. 1987 Mar 15;262(8):3852–3857. [PubMed] [Google Scholar]
  6. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Etienne-Smekens M., Vandenbussche P., Content J., Dumont J. E. (2'-5')Oligoadenylate in rat liver: modulation after partial hepatectomy. Proc Natl Acad Sci U S A. 1983 Aug;80(15):4609–4613. doi: 10.1073/pnas.80.15.4609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grabowski P. J., Seiler S. R., Sharp P. A. A multicomponent complex is involved in the splicing of messenger RNA precursors. Cell. 1985 Aug;42(1):345–353. doi: 10.1016/s0092-8674(85)80130-6. [DOI] [PubMed] [Google Scholar]
  9. Green M. R. Pre-mRNA splicing. Annu Rev Genet. 1986;20:671–708. doi: 10.1146/annurev.ge.20.120186.003323. [DOI] [PubMed] [Google Scholar]
  10. Hovanessian A. G., Laurent A. G., Chebath J., Galabru J., Robert N., Svab J. Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies. EMBO J. 1987 May;6(5):1273–1280. doi: 10.1002/j.1460-2075.1987.tb02364.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hovanessian A. G., Svab J., Marié I., Robert N., Chamaret S., Laurent A. G. Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells. J Biol Chem. 1988 Apr 5;263(10):4945–4949. [PubMed] [Google Scholar]
  12. Justesen J., Ferbus D., Thang M. N. 2'5' oligoadenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2'5' oligoadenylates and 2'5' co-oligonucleotides. Nucleic Acids Res. 1980 Jul 25;8(14):3073–3085. doi: 10.1093/nar/8.14.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Justesen J., Ferbus D., Thang M. N. Elongation mechanism and substrate specificity of 2',5'-oligoadenylate synthetase. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4618–4622. doi: 10.1073/pnas.77.8.4618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kerr I. M., Brown R. E. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A. 1978 Jan;75(1):256–260. doi: 10.1073/pnas.75.1.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kimchi A., Shulman L., Schmidt A., Chernajovsky Y., Fradin A., Revel M. Kinetics of the induction of three translation-regulatory enzymes by interferon. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3208–3212. doi: 10.1073/pnas.76.7.3208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Konarska M. M., Sharp P. A. Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes. Cell. 1987 Jun 19;49(6):763–774. doi: 10.1016/0092-8674(87)90614-3. [DOI] [PubMed] [Google Scholar]
  17. Krainer A. R., Maniatis T. Multiple factors including the small nuclear ribonucleoproteins U1 and U2 are necessary for pre-mRNA splicing in vitro. Cell. 1985 Oct;42(3):725–736. doi: 10.1016/0092-8674(85)90269-7. [DOI] [PubMed] [Google Scholar]
  18. Krainer A. R., Maniatis T., Ruskin B., Green M. R. Normal and mutant human beta-globin pre-mRNAs are faithfully and efficiently spliced in vitro. Cell. 1984 Apr;36(4):993–1005. doi: 10.1016/0092-8674(84)90049-7. [DOI] [PubMed] [Google Scholar]
  19. Nilsen T. W., Baglioni C. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2600–2604. doi: 10.1073/pnas.76.6.2600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nilsen T. W., Maroney P. A., Robertson H. D., Baglioni C. Heterogeneous nuclear RNA promotes synthesis of (2',5')oligoadenylate and is cleaved by the (2',5')oligoadenylate-activated endoribonuclease. Mol Cell Biol. 1982 Feb;2(2):154–160. doi: 10.1128/mcb.2.2.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Padgett R. A., Grabowski P. J., Konarska M. M., Seiler S., Sharp P. A. Splicing of messenger RNA precursors. Annu Rev Biochem. 1986;55:1119–1150. doi: 10.1146/annurev.bi.55.070186.005351. [DOI] [PubMed] [Google Scholar]
  22. Reed R., Griffith J., Maniatis T. Purification and visualization of native spliceosomes. Cell. 1988 Jun 17;53(6):949–961. doi: 10.1016/s0092-8674(88)90489-8. [DOI] [PubMed] [Google Scholar]
  23. Ruskin B., Green M. R. An RNA processing activity that debranches RNA lariats. Science. 1985 Jul 12;229(4709):135–140. doi: 10.1126/science.2990042. [DOI] [PubMed] [Google Scholar]
  24. Spann P., Feinerman M., Sperling J., Sperling R. Isolation and visualization of large compact ribonucleoprotein particles of specific nuclear RNAs. Proc Natl Acad Sci U S A. 1989 Jan;86(2):466–470. doi: 10.1073/pnas.86.2.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sperling R., Sperling J., Levine A. D., Spann P., Stark G. R., Kornberg R. D. Abundant nuclear ribonucleoprotein form of CAD RNA. Mol Cell Biol. 1985 Mar;5(3):569–575. doi: 10.1128/mcb.5.3.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. St Laurent G., Yoshie O., Floyd-Smith G., Samanta H., Sehgal P. B., Lengyel P. Interferon action: two (2'-5')(A)n synthetases specified by distinct mRNAs in Ehrlich ascites tumor cells treated with interferon. Cell. 1983 May;33(1):95–102. doi: 10.1016/0092-8674(83)90338-0. [DOI] [PubMed] [Google Scholar]
  27. Stark G. R., Dower W. J., Schimke R. T., Brown R. E., Kerr I. M. 2-5A synthetase: assay, distribution and variation with growth or hormone status. Nature. 1979 Mar 29;278(5703):471–473. doi: 10.1038/278471a0. [DOI] [PubMed] [Google Scholar]
  28. Wallace J. C., Edmonds M. Polyadenylylated nuclear RNA contains branches. Proc Natl Acad Sci U S A. 1983 Feb;80(4):950–954. doi: 10.1073/pnas.80.4.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wells J. A., Swyryd E. A., Stark G. R. An improved method for purifying 2',5'-oligoadenylate synthetases. J Biol Chem. 1984 Jan 25;259(2):1363–1370. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES